SEC Form 4 research
| Issuer | Helus Pharma Inc. |
|---|---|
| Tickers | HELP, CYBN |
| Reporting owners | 8 |
| Officers and directors | 4 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-30 | So Eric H. L. | A | 248,000 | Not reported | Not reported |
| 2026-10-01 | 2026-09-29 | Cavers Greg | P | 3,000 | $12.91 | Not reported |
| 2026-10-01 | 2026-09-30 | Glavine Paul | A | 248,000 | Not reported | Not reported |
| 2026-09-21 | 2026-09-21 | Halstead Michael | P | 100,000 | $13.47 | Not reported |
| 2026-09-11 | 2026-09-08 | Glavine Paul | P | 100,000 | $12.47 | Not reported |
| 2026-09-11 | 2026-09-08 | Glavine Paul | P | 100,000 | $12.47 | Not reported |
| 2026-09-11 | 2026-09-08 | So Eric H. L. | P | 100,000 | $12.39 | Not reported |
| 2026-09-10 | 2026-09-04 | So Eric H. L. | P | 100,000 | $12.09 | Not reported |
| 2026-09-10 | 2026-09-03 | Glavine Paul | P | 100,000 | $11.78 | Not reported |
| 2026-09-09 | 2026-09-01 | So Eric H. L. | P | 95,000 | $11.81 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.